CollPlant Biotechnologies Ltd (OPHI) income statement
OPHINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as CLGN
$3.40−0.20 (-5.56%)
Close on Nov 18, 2026Market cap $4.91MP/E –Yield –
CollPlant Biotechnologies Ltd income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- 64.8%
- Operating margin
- -484.3%
- Net margin
- -484.6%
- Return on equity, FY2025
- -117.6%
Financial strength
- Current ratio
- 1.57
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 102.9%
Valuation
- P/E ratio
- –
- Price to sales
- 2.07
- Price to book
- 1.67
- Dividend yield
- –
See a number that looks wrong?